Benzinga | May 25, 2021 06:36AM EDT

Barclays Initiates Coverage On Tandem Diabetes Care with Underweight Rating, Announces Price Target of $90

Barclays analyst Travis Steed initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Underweight rating and announces Price Target of $90.